Claims for Patent: 7,754,424

Summary for Patent: 7,754,424

Title:	Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidase M and the human mouse double minute 2 homolog
Abstract:	The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s):	Ryan; James W. (Augusta, GA)
Assignee:	Ryogen LLC (N/A)
Application Number:	10/608,463
Patent Claims:	1. An isolated nucleic acid molecule 20-51039 contiguous nucleotides in length consisting of a reverse or forward strand of a region of SEQ ID NO:4, wherein said region is selected from the group consisting of a 5'-non coding region between nucleotides 51039-41739 of SEQ ID 4; a 3'-non-coding region between nucleotides 9503-1 of SEQ ID NO:4; a contiguous intron-exon region between nucleotides 41738-9502 of SEQ ID NO:4, wherein a sequence segment between nucleotides 41738-9502 of SEQ ID NO:4 encodes human mouse double minute 2 homolog depicted in SEQ ID NO:2; a contiguous exon-intron region between nucleotides 41738-9502 of SEQ ID NO:4, wherein a sequence segment between nucleotides 41738-9502 of SEQ ID NO:4 encodes human mouse double minute 2 homolog depicted in SEQ ID NO:2; an intron depicted in nucleotides 36385-40645, 36309-33127, 32994-29616, 29564-25577, 25507-25384, 25287-21169, 21006-14110, 13953-13267, and/or 13188-10665; a region comprising a dinucleotide of the following group: 41739-41738, 40645-40646, 36309-36310, 36384-36385, 32994-32995, 33126-33127, 29564-29565, 29615-29616, 25507-25508, 25287-25288, 25383-25384, 25576-25577, 21006-21007, 21168-21169, 14109-14110, 13953-13954, 13266-13267, 13188-13189, 10664-10665 and/or 9504-9503; a transcription binding site selected from the group consisting of TABLE-US-00004 BINDING SITES huMDM2, location in SEQ ID NO:4 AP1_C: 36-46, 2876-2886; AP4_Q5: 7944-7980; AP4_Q6: 7943-59, 8924-8940, 9294-9310; ARNT_01: 1682-1706, 2193-2217, 9201-9225; BRN2_01: 1040-1058,7803-7821; CAAT_01: 3292-3306; CDPCR3HD_01: 6522-6540; CEBPB_01: 1424-1438, 3917-3931, 4178-4192,4787-4801, 6855-6869; CREL_01: 5630-5642; DELTAEF1_01: 83-95, 6328-6340; FREAC7_01: 2757-2773, 5154-5170, 5823-5839; GATA1_04: 4846-4858, 7017-7029; GATA1_05: 8464-8476; GATA2_02: 6045-6057, 6073-6085, 6142-6154; GATA2_03: 2489-2501, 3323-3335, 3384-3396, 7393-7405: GATA3_02: 3264-3276, 6870-6882: GATA3_03: 40-52, 5729-5741, 6529-6541, 6874-6886, 7041-7053, 7589-7601; GATA_C: 7349-7361, 8188-8200; HFH2_01: 1743-1759, 7995-8011; HFH3_01: 502-518, 1739-1755, 4160-4176, 9402-9418, 9418-9434; HFH8_01: 8184-8200; IK2_01: 951-963, 3588-3600; MZF1_01: 1202-1210, 1447-1455, 4997-4005, 5424-5432; NF1_Q6: 1480-1500, 8166-8182; NFAT_Q6: 4190-4208, 6009-6027; NKX25_01: 741-755, 1648-1662, 1885-1899, 1984-1998, 3609-3623,4928-4942, 5060-5074, 5889-5903, 8850-8864, 9190-9204; NKX25_02: 2584-2599, 2970-2984, 4644-4658, 5179-5193, 6482-6496; NMYC_01: 2560-2572; RORA1_01: 220-238, 2638-2656; S8_01: 4644-4656, 4842-4854, 4845-4857, 5200-5212, 5371-5383, 5735-5747, 6482-6494, 6541-6553, 6544-6556, 6772-6784, 7270-7292, 7273-7285; SOX5_01: 1355-1371, 1430-1446, 3094-3110, 3155-3171, 4669-4685, 4692-4708, 4789-4805; SRY_02: 4164-4180, 5665-5681; TATA_01: 1261-1277, 2574-2590, 2723-2739, 2733-2749, 2770-2786, 4199-4215, 4206-4222; TATA_C: 5900-5916, 7456-7472, 7702-7718, 7917-7933; and XFD2_01: 7702-7218,7917-7933; a transcription binding site selected from the group consisting of TABLE-US-00005 BINDING SITES huMDM2, location in SEQ ID NO:4 AP1_C: 12109-12119, 12695-12705, 22600-22610, 24166- 24176, 31311-31321, 35234-35244, 39184-39194; AP1_Q2: 11952-11962, 12068-12078, 14798-14808, 21748- 21758, 22613-22623, 23676-23686, 26562-26572, 30046-30056; AP1_Q4: 12695-12705, 31311-31321, 35234-35244, 36295- 36305, 38784-38794, 39188-39198; AP4_Q6: 31635-31651; BRN2_01: 13448-13466, 14764-14782, 28094-28112, 40027-40045; CAAT_01: 11288-11302, 15054-15068; CDPCR3HD_01: 11286-11304, 13284-13302, 20846-20864, 29344-29362; CEBPB_01: 29241-29255; CREL_01: 36091-36103, 38873-38885; DELTAEF1_01: 18083-18095, 20385-20397, 26955-26967; FREAC7_01: 11982-11998, 15187-15202, 16523-16539, 16529- 16545, 16587-16603, 16604-16620, 16676-16642, 16633-16649, 16644-16660, 16650-16666, 16657- 16673, 16673-16689, 16762-16778, 21332-21348, 25689-25700, 26529-26545, 27767-27783, 29495-29511; GATA1_02: 10916-10928, 15775-15789, 18162-18174, 26088- 26100, 32518-32530; GATA1_03: 28012-28024; GATA1_04: 11153-11165, 11630-11642, 13778-13790, 17439- 17451, 19300-19312, 21606-21618, 22743-22755, 23747-23759, 25806-25818, 26529-26541, 29424- 29436, 30455-30467, 32761-32778, 33352-33364, 33960-33972, 36101-36113, 40007-40019; GATA1_05: 11590-11602, 26550-26562, 36737-36749; GATA1_06: 18772-18784, 23054-23066, 35568-35580, 37855-37867; GATA2_02: 20755-20767, 30830-30842, 34755-34767, 36285- 36297, 39143-39155, 39641-39653, 40586-40598; GATA2_03: 13535-13547, 22711-22723, 23161-23173, 25028- 25040, 27237-27249, 36277-36289; GATA3_02: 11558-11570, 16470-16482, 17225-17237, 19619- 19631, 22156-22168, 22443-22455, 24713-24725, 27619-27631, 32716-32728, 34124-34136, 34163- 34175, 36832-36844, 38403-38415; GATA3_03: 10869-10881, 11515-11527, 13845-13857, 17221- 17233, 18952-18964, 20050-20062, 40171-40183; GATA_C: 15848-15860, 18899-18911, 23640-23652, 29072- 29084, 30881-30893, 33198-33210, 37472-37484, 38621-38633; GFI1_01: 35469-35481, 35492-35504; HFH2_01: 15939-15955, 24636-24652, 25866-25882, 32171- 32187, 35372-35388, 39457-35473; HFH3_01: 13340-13356, 19218-19234, 21328-21344, 21336- 21352, 21344-21360, 28062-28078, 32125-32141; HFH8_01: 14133-14149, 22578-22584; HNF3B_01: 13150-13166, 16505-16521, 25264-25280, 29443- 29459, 37654-37670; IK2_01: 11547-11559, 17144-17156, 18961-18973, 23883- 23895, 27617-27629, 28908-28920, 29241-29253, 30752-30764, 34768-34780; LYF1_01: 12319-12331, 19191-19203, 37226-37238, 39430-39442; MAX_01: 22974-22986, 33339-33351; MZF1_01: 26105-26113, 35187-35195; NF1_Q6: 12048-12064, 33334-33354; NFAT_Q6: 13295-13313, 14157-14175, 14311-14329, 14414- 14432, 18269-18287, 19326-19344, 20801-20819, 21177-21195, 22537-22555, 23861-23879, 25392- 25410, 25879-25897, 27524-27542, 30636-30654, 30718-30736, 31525-31543, 33655-33673, 34726- 34744, 34917-34535, 34990-35008, 35979-35997, 36479-36493, 36577-36595, 37154-37172, 40224- 40242, 40365-40383; NKX25_01: 12041-12055, 12340-12354, 12471-12485, 12742- 12756, 12877-12891, 13849-13863, 18995-19009, 21440-21454, 21883-21897, 28426-28440, 30964- 30978, 32033-32047, 32265-32279; NKX25_02: 10998-11012, 12711-12725, 14131-14145, 14726-14740, 16024-16038; NMYC_01: 18753-18765, 18754-18766, 23076-23088, 30534-30546, 34400-34412; RORA1_01: 13134-13152, 22966-22984, 24934-24952, 33341-33359, 34760-34778; S8_01: 11000-11012, 11977-11989, 12048-12060, 12051- 12063, 13747-13759, 13923-13935, 13926-13938, 14676-14688, 14679-14691, 16026-16038, 16313- 16325, 16316-16328, 17515-17527, 20756-20768, 20759-20771, 23154-23166, 23157-23169, 25198- 25210, 25201-25213, 26651-26663, 27508-27520, 27511-27523, 29450-29462, 29478-28490, 29775- 29787, 29778-29790, 29813-29825, 29816-29828, 31329-31341, 31677-31689, 31680-31692, 31732- 31744, 31735-31747, 36137-36149, 36140-36152, 36812-36824, 36815-36827, 37413-37425, 38679- 38691, 39474-39486, 39477-39489; SOX5_01: 27397-27413, 27572-27588, 28100-28116, 29230- 29246, 29439-29455, 30690-30706, 31595-31611, 33871-33887, 34113-34129, 34624-34640, 37668- 37684, 38582-38598, 39124-39140, 40410-40426; SRY_02: 20016-20032, 22410-22426, 27329-27345, 29162- 29178, 29499-29515, 30646-30662, 31503-31519, 35928-35944, 37324-37340; TATA_01: 32722-32738, 32729-32745, 32807-32823, 33825- 33841, 34120-34136, 35433-35449, 36593-36609; TATA_C: 11015-11031, 11817-11833, 13635-13651, 14930-14946; TCF11_01: 18543-18549, 22574-22580, 31281-31297, 31489-31505, 38754-38770; USF_01: 23075-23087, 32577-32589; VMYB_02: 11526-11538, 17384-17396, 18400-18412, 19549- 19561, 22188-22200, 40486-40508 and XFD2_01: 16620-16636, 18153-18169, 22102-22118, 23141-23157; And a transcription binding site selected from the group consisting of TABLE-US-00006 BINDING SITES huMDM2, 1 location in SEQ ID NO:4 AP1_C: 44584-44594, 49069-49079: AP1_Q2: 42174-42184, 45217-45227, 48422-48422, 50447-50457; AP1_Q4: 42702-42712, 50806-50816; AP4_Q6: 42117-42133, 42118-42134, 42244-42260, 45432-45448; 45433-45449, 46609-46625; BRN2_01: 42310-42328, 44022-44040, 47514-47532, 48900-48918, 48967-48985; CAAT_01: 44866-44880; CDPCR3HD_01: 45671-45689, 49219-49237; CREL_01: 42437-42449, 49797-49809; FREAC7_01: 47026-47042, 47292-47308, 47658-47674; GATA1_02: 43482-43494, 48926-48938, 49284-49296; GATA1_03: 47371-47383; GATA1_04: 43054-43066, 43162-43162, 43967-43979, 45464- 45476, 45916-45928, 47763-47775; GATA1_05: 49319-49331, 49459-49471; GATA1_06: 47590-47602; GATA2_02: 42660-42672, 43475-43487; GATA2_03: 43714-43726, 50948-50960; GATA3_02: 49155-49167, 49844-49856; GATA3_03: 42202-42214, 44810-44822, 48438-48450, 49136- 49148, 49337-49349, 49869-49881; GATA_C: 44011-44023, 45256-45268, 45823-45835, 47915- 47927, 49201-49213, 49573-49585; GFI1_01: 46606-46618, 47063-47075; HFH3_01: 47030-47046, 47284-47300, 47288-47304; IK2_01: 45275-45287; LYF1_01: 44564-44576, 46991-47003, 49567-49579; MAX_01: 43234-43246, 48726-48738; MZF1_01: 41772-41780, 42290-42298, 42295-42303, 44507- 44515, 45105-45113, 45203-45211, 49948- 49956, 50774-50782; NF1_Q6: 50209-50229; NFAT_Q6: 42061-42079, 44418-44436, 46399-46417, 47974-47992, 49267-49285, 49964-49982, 50392-50410; NKX25_01: 42394-42408, 43507-43521, 46115-46129; RORA1_01: 45073-45091, 48718-48736; S8_01: 43552-43564, 45214-45226, 47160-47172, 48419- 48431, 49295-49307, 50379-50391; SOX5_01: 43716-43732, 46351-46367, 47156-47172, 47774- 47790, 47868-47884, 47974-47990, 48915-48931, 50323-50339; TATA_01: 45588-45604, 47625-47641, 48026-48042, 48659- 48675, 49056-49072, 49079-49095, 49152-49168; TCF11_01: 49115-49131; VMYB_02: 42010-42022, 42279-42291, 44651-44663; and XFD2_01: 42870-42886, 42910-42926. 2. A composition comprising the nucleic acid molecule of claim 1 and a carrier. 3. A kit comprising the nucleic acid molecule of claim 1. 4. The kit according to claim 3, in which the nucleic acid molecule is labeled with a detectable substance. 5. A solid support comprising the nucleic acid molecule of claim 1. 6. The solid support of claim 5 wherein said support is a microarray. 7. The solid support of claim 6, which further comprises a nucleic acid molecule encoding human mouse double minute 2 homolog, complementary sequence thereof or a portion of said nucleic acid molecule containing at least 20 contiguous nucleotides. 8. A method for detecting the presence or absence of SEQ ID NO:4 or its fully complementary sequence in a sample, said method comprising (a) contacting the sample with the nucleic acid molecule of claim 1 and (b) determining whether the nucleic acid molecule binds to said nucleic acid sequence in the sample. 9. An isolated nucleic acid molecule 20-5000 contiguous nucleotides in length consisting of a reverse or forward strand of a contiguous exon-intron region between nucleotides 41738-9502 of SEQ ID NO:4 or a contiguous intron-exon region between nucleotides 41738-9502 of SEQ ID NO:4, wherein a sequence segment between 41738-9502 of SEQ ID NO:4 encodes human mouse double minute 2 homolog depicted in SEQ ID NO:2. 10. The isolated nucleic acid molecule of claim 9, wherein said nucleic acid molecule is 20-5000 contiguous nucleotides in length and comprises nucleotides 41739-41738, 40645-40646, 36309-36310, 36384-36385, 32994-32995, 33126-33127, 29564-29565, 29615-29616, 25507-25508, 25287-25288, 25383-25384, 25576-25577, 21006-21007, 21168-21169, 13953-13954, 14109-14110, 13188-13189, 13266-13267, 10664-10665 and/or 9504-9503 of SEQ ID NO:4 or their reverse strands. 11. A microarray comprising a plurality of the nucleic acid molecules of claim 1. 12. The microarray of claim 11 wherein said microarray further comprises a nucleic acid molecule encoding human mouse double minute 2 homolog, complementary sequence thereof or a portion of said nucleic acid molecule containing at least 20 contiguous nucleotides. 13. A method for detecting the nucleic acid molecule of claim 1 in a sample comprising (a) amplifying said nucleic acid molecule and (b) detecting the presence of the amplified nucleic acid molecule of (a) wherein amplifying is carried out by polymerase chain reaction.

Details for Patent 7,754,424

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-03-29